Nutrition & metabolism · Arkansas
Nutrition and metabolism studies in Arkansas
12 studies have at least one recruiting site in Arkansas. Nutrition and metabolism studies look at diets, supplements, metabolic conditions and fatty liver disease. Some are run by universities with controlled meals.
12 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Little Rock, AR + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Little Rock, AR + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Little Rock, AR + 131 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Little Rock, AR + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated…
Eccogene
- Location
- Little Rock, AR + 65 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Eli Lilly and Company
- Location
- North Little Rock, AR + 136 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
GlaxoSmithKline
- Location
- Little Rock, AR + 10 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
GlaxoSmithKline
- Location
- Little Rock, AR + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
Altimmune, Inc.
- Location
- North Little Rock, AR + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Little Rock, AR + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Rivus Pharmaceuticals, Inc.
- Location
- Little Rock, AR + 30 other US sites
- Eligibility basics
- Ages 30+
- RecruitingHealthy volunteers
Delivering HOPE (Helping Women Optimize Prenatal Equity)
University of Arkansas
- Location
- Corning, AR + 6 other US sites
- Eligibility basics
- Ages 16–44 · Women only
Who these studies look for
Expect limits on supplements, alcohol and diet changes during the study, and sometimes a set BMI range.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Are meals provided in nutrition studies?
Sometimes. Controlled-feeding studies provide food; others ask you to follow a plan at home. The listing summary and the study team explain what is involved.